Weathering the COVID-19 Storm: Incorporating Beliefs, Knowledge, and Research to Boost Confidence in Pharmaceutical Sales Forecasting

In this webinar, KMK Consulting, Inc. will share real-world approaches to forecasting and market research to more accurately predict commercial outcomes in this unprecedented time.

Using a deidentified composite case study from multiple KMK client projects, we will show you how to design predictable forecasting models to implement with your own company operations–even during market turmoil. We will discuss how forecasting models can positively impact product manufacturing, board and Wall Street expectations, and sales force incentive compensation.

We will be running this webinar on two separate occasions and you can register for May 19th or May 21st by clicking the respective link below:

Register: Tuesday, May 19, 2020 12pm-1pm ET

Register: Thursday, May 21, 2020 11am-12pm ET

As we weather the current storm, a reliable forecast will play a vital role in directing business planning and operations, delivering customer satisfaction, and maintaining a competitive advantage.

The pharmaceutical industry is currently facing unprecedented challenges: closed physician practices, cancellation of surgical procedures, paused sales team activities, revenue impact and a general economic downturn. Commercial leaders are confronted with short- and long-term uncertainty.

A predictable forecasting model and process is essential for directing specific actions for business planning and operations, maintaining customer satisfaction, and keeping a competitive advantage in the market.

In this 60-minute webinar, Paul Johnson and Greg Chu from KMK Consulting Inc. will share with you:

· A framework to break a large uncertain event into small quantifiable questions
· Critical milestones and commonly used tactics to validate your forecast
· Recent case studies of how KMK built a framework to improve accuracy and confidence with launch forecast while addressing the COVID-19 impact
· Challenges to building a robust forecast

Mr. Johnson and Mr. Chu each have more than 25 years of industry experience with a focus on forecasting activities. Their background and expertise include working with both emerging pharmaceutical firms as well as established firms.

KMK Consulting, Inc. https://kmkconsultinginc.com